(주)코스메디션

{
  "address": "부산 기장군",
  "ceo_name": "김성철",
  "certificate": [
    {
      "cert_number": "20140109110",
      "changes": "",
      "disclosure_date": "2014-08-08",
      "first_cert_date": "2014-08-08",
      "no": "1",
      "type": "기술평가보증기업(기금)",
      "valid_period": "2014-08-08 ~ 2016-08-07"
    },
    {
      "cert_number": "20160401912",
      "changes": "",
      "disclosure_date": "2016-11-18",
      "first_cert_date": "2014-08-08",
      "no": "2",
      "type": "기술평가대출기업(중진공)",
      "valid_period": "2016-11-18 ~ 2018-11-17"
    },
    {
      "cert_number": "20180113470",
      "changes": "",
      "disclosure_date": "2018-11-27",
      "first_cert_date": "2014-08-08",
      "no": "3",
      "type": "기술평가보증기업(기금)",
      "valid_period": "2018-11-18 ~ 2020-11-17"
    },
    {
      "cert_number": "20200116007",
      "changes": "",
      "disclosure_date": "2020-12-10",
      "first_cert_date": "2014-08-08",
      "no": "4",
      "type": "기술평가보증기업(기금)",
      "valid_period": "2020-11-18 ~ 2022-11-17"
    },
    {
      "cert_number": "20221221020022",
      "changes": "",
      "disclosure_date": "2022-12-21",
      "first_cert_date": "2014-08-08",
      "no": "5",
      "type": "연구개발유형",
      "valid_period": "2022-11-18 ~ 2025-11-17"
    },
    {
      "cert_number": "20251217020003",
      "changes": "",
      "disclosure_date": "2025-12-17",
      "first_cert_date": "2014-08-08",
      "no": "6",
      "type": "연구개발유형",
      "valid_period": "2025-11-18 ~ 2028-11-17"
    }
  ],
  "company_name": "(주)코스메디션",
  "corp_no": "180111-*******",
  "financials": {
    "2022": {
      "capital_stock": 100000000,
      "cost_of_sales": 709828000,
      "current_assets": 1001689000,
      "current_liabilities": 187401000,
      "gross_profit": 853642000,
      "net_income": 182704000,
      "net_income_bs": 180717000,
      "non_current_assets": 196043000,
      "non_current_liabilities": 351945000,
      "non_operating_expenses": 18277000,
      "non_operating_income": 54104000,
      "operating_profit": 146877000,
      "revenue": 1563471000,
      "sga_expenses": 706765000,
      "total_assets": 1197732000,
      "total_equity": 658386000,
      "total_liabilities": 539345000
    },
    "2023": {
      "capital_stock": 100000000,
      "cost_of_sales": 770199000,
      "current_assets": 833943000,
      "current_liabilities": 97572000,
      "gross_profit": 986915000,
      "net_income": 51042000,
      "net_income_bs": 50441000,
      "non_current_assets": 304957000,
      "non_current_liabilities": 332500000,
      "non_operating_expenses": 68160000,
      "non_operating_income": 42326000,
      "operating_profit": 76876000,
      "revenue": 1757114000,
      "sga_expenses": 910039000,
      "total_assets": 1138900000,
      "total_equity": 708828000,
      "total_liabilities": 430072000
    },
    "2024": {
      "capital_stock": 100000000,
      "cost_of_sales": 1230811000,
      "current_assets": 1293586000,
      "current_liabilities": 155801000,
      "gross_profit": 1426215000,
      "net_income": 293544000,
      "net_income_bs": 289686000,
      "non_current_assets": 345728000,
      "non_current_liabilities": 485000000,
      "non_operating_expenses": 45906000,
      "non_operating_income": 53776000,
      "operating_profit": 285674000,
      "revenue": 2657025000,
      "sga_expenses": 1140541000,
      "total_assets": 1639314000,
      "total_equity": 998513000,
      "total_liabilities": 640801000
    }
  },
  "industry": "물리, 화학 및 생물학 연구개발업",
  "investment": [],
  "main_products": "물리, 화학　및　생물학　연구개발업",
  "phone": "051-723-****",
  "years": [
    2024,
    2023,
    2022
  ]
}